REG - Creo Medical Group - Director/PDMR and PCA Share Dealings
13/03/2023 18:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230313:nRSM8136Sa&default-theme=true
RNS Number : 8136S Creo Medical Group PLC 13 March 2023
LEI: 213800H188ZDCWWXFA21
13 March 2023
Creo Medical Group plc
("Creo" or the "Company")
Director/PDMR and PCA Share Dealings
Further to the announcements made on 16 February 2023 and 8 March 2023, and
pursuant to the recent fundraising, the Company confirms that each of the
Company's Directors, Luis Collantes, a member of the Company's senior
leadership team and a director of various of the Company's subsidiaries and
certain PCAs, have either themselves or through parties affiliated with them
acquired New Ordinary Shares at the Issue Price of 20 pence per Ordinary Share
as follows:
Director/PDMR Name No. of New Ordinary Shares Acquired Resultant Shareholding post transaction % of voting rights post transaction
Charles Spicer 165,119 308,530 0.09%
Craig Gulliford* 1,000,000 1,630,466 0.46%
Richard Rees 2,715,322 2,805,902 0.79%
Professor Christopher Hancock 383,171 4,802,352 1.36%
David Woods 415,255 440,255 0.13%
John Bradshaw 1,265,135 1,371,082 0.39%
Ivonne Cantu 125,000 125,000 0.04%
Luis Collantes** 4,442,485 4,442,485 1.27%
* These 1,000,000 shares are held by the spouse of Craig Gulliford
**Shares held via Monkey Business Consultants SL, a company owned and managed
by Luis Collantes.
Creo Medical Group plc www.creomedical.com (http://www.creomedical.com)
Richard Rees (CFO) +44 (0)1291 606 005
Cenkos Securities plc (Nominated Adviser, Joint Bookrunner and Joint Broker) +44 (0)20 7397 8900
Camilla Hume/Stephen Keys (NOMAD)
Russell Kerr/Michael Johnson (Sales)
Numis Securities Limited (Joint Bookrunner and Joint Broker) +44 (0)20 7260 1000
Freddie Barnfield / James Black / Duncan Monteith
William Baunton (ECM)
Walbrook PR Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com
Paul McManus / Sam Allen / Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303
Phillip Marriage / +44 (0)7867 984 082
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Charles Spicer
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 165,119
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Kathryn Hogg (spouse of Craig Gulliford)
2 Reason for the notification
a) Position/status PCA to Craig Gulliford, Chief Executive Officer
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 1,000,000
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Richard Rees
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 2,715,322
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Professor Christopher Hancock
2 Reason for the notification
a) Position/status Chief Technology Officer
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 383,171
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name David Woods
2 Reason for the notification
a) Position/status Chief Commercial Officer
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 415,255
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name John Bradshaw
2 Reason for the notification
a) Position/status Independent Non-Executive Director
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 1,265,135
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Ivonne Cantu
2 Reason for the notification
a) Position/status Independent Non-Executive Director
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 125,000
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Luis Collantes
2 Reason for the notification
a) Position/status PDMR
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Creo Medical Group plc
b) LEI 213800H188ZDCWWXFA21
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code GB00BZ1BLL44
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volumes(s) Price(s) Volume(s)
£0.20 4,442,485
d) Aggregated information N/A single transaction
Aggregated volume N/A single transaction
Price N/A single transaction
e) Date of the transaction 9 March 2023
f) Place of the transaction London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFLTVLIVLIVRecent news on Creo Medical
See all newsREG - Creo Medical Group - Final Results
AnnouncementREG - Creo Medical Group - Directorate Changes
AnnouncementRCS - Creo Medical Group - Creo Medical receives King’s Award for Enterprise
AnnouncementREG - Creo Medical Group - Notice of Results
AnnouncementREG - Creo Medical Group - NHS Speedboat data demonstrates savings
Announcement